GRAL GRAIL, Inc. - Common Stock

NASDAQ · Biotechnology · Ver en SEC EDGAR ↗
$75,83
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 6, 2026

Acerca de GRAIL, Inc. - Common Stock Descripción general de la empresa de Wikipedia

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

Leer más

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.

In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.

Activities

Illumina's own research showed that repeatedly sequencing DNA in the bloodstream made it possible to detect floating bits of DNA from cancer cells more accurately. It initially aimed to recruit greater than 100,000 people into its clinical trials in order to accumulate the sizeable data required to detect and interpret cancer biomarkers.

Galleri test

As of November 2020 Galleri investigated three multi-cancer screening tests.

In June 2021 Galleri launched their liquid biopsy or multi-cancer early detection test (MCED), which Grail called the Galleri test. Grail promoted the test as a "groundbreaking and potentially life-saving advance", although the results of early trials were poor. A subsequent large-scale NHS England trial was described as overhyped and unethical. As of 2024, Grail was facing discontent and legal action from investors.

In June 2025, an article in the New Yorker discussed an interview of their medicine and science writer regarding the test and its recent history with a focus on its potential for adaptation as research continues in its product development through clinical investigations.

On 17 October 2025, BBC news carried positive coverage of test results just presented at the European Society for Medical Oncology. However, as of October 20, 2025 the results of the PATHFINDER 2 study have yet to be peer reviewed or published. Eric Topol reported a sensitivity of only 40% these false negatives failed to discover cancer that emerged during the 12-month follow-up.

Company history

Grail began as a San Francisco biotechnology and pharmaceutical startup company in 2015, the parent company being Illumina of San Diego, which produces most of the DNA sequencing machines that scientists use to study human biology and diagnose rare genetic diseases. Richard Klausner, then chief medical officer at Illumina and former director of the National Cancer Institute, advocated for the new business. According to the San Francisco Business Times, he correctly predicted how DNA sequencing technology would make it possible to detect evidence of a tumor from a blood sample. He also joined Grail's board of directors. According to Forbes in 2017, 20% of Grail's profits are kept by Illumina.

In September 2020, Illumina announced an agreement to purchase Grail outright for $7.1 billion.

On November 27, 2020, Grail announced a commercial partnership with the National Health Service (England) (NHS), to trial the Galleri test, reporting in 2026.

In March 2021, the Federal Trade Commission (FTC) sued to block the vertical merger. In September 2022, an administrative judge ruled against the FTC's position on antitrust grounds.

In June 2023, Grail disclosed that letters were mailed to 408 patients incorrectly informing them that they may have cancer. The company blamed the incident on PWNHealth, saying that it was due to a software configuration issue, not due to incorrect Galleri test results.

In October 2023, the European Commission ordered Grail to be divested from Illumina within the next twelve months. The European Commission (EC) has since approved Illumina's divestment plan for separating from Grail. Illumina has set a goal of finalizing the divestment terms by the end of the second quarter of 2024. In April 2024, the EC approved Illumina's plan, allowing Illumina to explore either a trade sale or a capital markets transaction (spin-off) to divest Grail. In May 2024, Illumina publicly filed a Form 10 registration statement with the U.S. SEC, a necessary step for a potential capital markets separation of Grail. If a capital markets transaction occurs, Illumina must capitalize Grail with around $1 billion to fund 2.5 years of operations per the EC's divestment plan. The spinoff was completed in June 2024, with Grail trading on the Nasdaq with ticker symbol GRAL and Illumina retaining a 14.5% share of Grail.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

GRAL Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$75.83
Capitalización Bursátil
$3.12T
P/E (TTM)
-6961.3
BPA (TTM)
$-11.11
Ingresos (TTM)
$147M
Rendimiento div.
ROE
-16.7%
Deuda/Capital
Rango 52S
$30 – $119

GRAL Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $147M
4-point trend, +164.9%
2023-01-01 2025-12-31
BPA $-11.11
4-point trend, +93.6%
2023-01-01 2025-12-31
Flujo de caja libre $-300M
2-point trend, +48.5%
2024-12-31 2025-12-31
Márgenes -277.5%

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
GRAL
Mediana de Pares
P/E (TTM)
2-point trend, -2642.6%
-6961.3
P/S (TTM) (P/V (TTM))
2-point trend, +386.9%
21194.3
18.3
P/B (P/C)
2-point trend, +454.0%
1210.0
3.3
Price / FCF (Precio / FCF)
2-point trend, -1007.9%
-10400.3

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
GRAL
Mediana de Pares
Operating Margin (Margen Operativo)
2-point trend, +78.1%
-382.0%
Net Profit Margin (Margen de Beneficio Neto)
2-point trend, +82.8%
-277.5%
-180.4%
ROA
2-point trend, +76.5%
-13.8%
-36.2%
ROE
2-point trend, +79.0%
-16.7%
-43.7%
ROIC
2-point trend, +79.7%
-16.7%

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
GRAL
Mediana de Pares
Current Ratio (Ratio corriente)
2-point trend, +12.3%
12.0
9.7
Quick Ratio (Ratio Rápido)
2-point trend, +10.3%
3.4

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
GRAL
Mediana de Pares
Revenue YoY (Ingresos interanuales)
4-point trend, +164.9%
17.2%
Revenue CAGR 3Y (Ingresos CAGR 3A)
4-point trend, +164.9%
38.4%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
GRAL
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
4-point trend, +93.6%
$-11.11

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
GRAL
Mediana de Pares

GRAL Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 15 analistas
  • Compra fuerte 4 26,7%
  • Compra 5 33,3%
  • Mantener 6 40,0%
  • Venta 0 0,0%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

8 analistas · 2026-08-19
Objetivo mediano $74.50 -1,8%
Objetivo medio $72.38 -4,6%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.61%
Período EPS Actual EPS est. Sorpresa
30 de junio de 2026 $-2.56 $-2.71 0.15%
31 de marzo de 2026 $-2.29 $-2.82 0.53%
31 de diciembre de 2025 $-2.44 $-2.76 0.32%
30 de septiembre de 2025 $-2.46 $-3.59 1.1%
30 de junio de 2025 $-3.18 $-3.64 0.46%
31 de marzo de 2025 $-3.10 $-4.17 1.1%

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
GRAL $3.45B -7.7 17.2% -277.5% -16.7%
RCUS $2.99B -7.2 -4.3% -142.9% -59.8%
VCYT $3.34B 51.3 16.0% 12.8% 5.2% 70.1%
IDYA $3.04B -27.0 3024.4% -52.0% -11.5%
CLDX $1.81B -7.0 -78.0% -16748.0% -43.8%
ARQT $3.58B -223.4 91.3% -4.3% -9.8%
IOVA $1.12B -2.5 60.6% -148.4% -56.0%
IMNM $2.43B -8.8 -23.2% -3060.0% -47.0%
IRON $3.01B -13.2 -31.3%
NRIX $1.80B -5.8 53.9% -314.9% -53.6%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 15
Datos anuales de Estado de resultados para GRAL
Métrica Tendencia 202520242023
Revenue 3-point trend, +58.1% $147M $126M $93M
R&D Expense 3-point trend, -42.2% $196M $322M $339M
SG&A Expense 3-point trend, -20.6% $159M $214M $200M
Operating Expenses 3-point trend, -55.9% $709M $2.31B $1.61B
Operating Income 3-point trend, +62.9% $-562M $-2.19B $-1.52B
Interest Income 3-point trend, +260.2% $29M $27M $8M
Other Non-op 3-point trend, -377.4% $-993.0K $64.0K $-208.0K
Pretax Income 3-point trend, +64.5% $-535M $-2.16B $-1.51B
Income Tax 3-point trend, -200.7% $-126M $-135M $-42M
Net Income 3-point trend, +72.1% $-408M $-2.03B $-1.47B
EPS (Basic) 3-point trend, +76.5% $-11.11 $-63.54 $-47.21
EPS (Diluted) 3-point trend, +76.5% $-11.11 $-63.54 $-47.21
Shares (Basic) 3-point trend, +18.4% 36,753,751 31,901,259 31,049,148
Shares (Diluted) 3-point trend, +18.4% 36,753,751 31,901,259 31,049,148
EBITDA 2-point trend, +74.3% $-562M $-2.19B ·
Balance general 25
Datos anuales de Balance general para GRAL
Métrica Tendencia 202520242023
Cash & Equivalents 3-point trend, +156.7% $250M $214M $97M
Receivables 3-point trend, +8.0% $18M $20M $17M
Prepaid Expense 3-point trend, -25.0% $15M $17M $20M
Current Assets 3-point trend, +511.2% $954M $820M $156M
PP&E (Net) 3-point trend, -39.0% $52M $69M $85M
PP&E (Gross) 3-point trend, +1.4% $122M $123M $121M
Accum. Depreciation 3-point trend, +98.2% $70M $54M $36M
Goodwill 2-point trend, -100.0% · $0 $889M
Intangibles 3-point trend, -31.1% $1.85B $2.02B $2.69B
Other Non-current Assets 3-point trend, -15.4% $7M $8M $8M
Total Assets 3-point trend, -25.3% $2.92B $2.98B $3.91B
Accounts Payable 3-point trend, -89.4% $2M $5M $20M
Accrued Liabilities 3-point trend, -13.4% $64M $57M $74M
Current Liabilities 3-point trend, -51.3% $80M $77M $164M
Capital Leases 3-point trend, -38.0% $43M $55M $70M
Deferred Tax 3-point trend, +564.0% $219M $346M $33M
Other Non-current Liabilities 3-point trend, +83.7% $3M $2M $1M
Total Liabilities 3-point trend, +28.6% $344M $480M $268M
Common Stock 2-point trend, +17.6% $40.0K $34.0K ·
Paid-in Capital 2-point trend, +3.9% $12.79B $12.31B ·
Retained Earnings 3-point trend, -31.3% $-10.21B $-9.80B $-7.78B
AOCI 3-point trend, +149.1% $3M $1M $1M
Stockholders' Equity 2-point trend, +3.0% $2.58B $2.50B ·
Liabilities + Equity 3-point trend, -25.3% $2.92B $2.98B $3.91B
Shares Outstanding 3-point trend, +40331360.00 40,331,360 33,893,409,000 0
Flujo de Efectivo 10
Datos anuales de Flujo de Efectivo para GRAL
Métrica Tendencia 202520242023
Stock-based Comp 3-point trend, -40.1% $58M $86M $97M
Deferred Tax 3-point trend, -230.7% $-126M $-134M $-38M
Amort. of Intangibles Flat — no change across 3 periods $134M $134M $134M
Operating Cash Flow 3-point trend, +49.8% $-299M $-577M $-596M
CapEx 3-point trend, -92.9% $909.0K $5M $13M
Investing Cash Flow 3-point trend, -560.0% $-85M $-551M $-13M
Financing Cash Flow 3-point trend, -8.7% $423M $1.24B $464M
Net Change in Cash 3-point trend, +127.0% $39M $116M $-145M
Taxes Paid $1M · ·
Free Cash Flow 2-point trend, +48.5% $-300M $-582M ·
Rentabilidad 7
Datos anuales de Rentabilidad para GRAL
Métrica Tendencia 202520242023
Operating Margin 2-point trend, +78.1% -382.0% -1743.0% ·
Net Margin 2-point trend, +82.8% -277.5% -1613.9% ·
Pretax Margin 2-point trend, +78.9% -363.2% -1721.7% ·
EBITDA Margin 2-point trend, +78.1% -382.0% -1743.0% ·
ROA 2-point trend, +76.5% -13.8% -58.8% ·
ROE 2-point trend, +79.0% -16.7% -79.6% ·
ROIC 2-point trend, +79.7% -16.7% -82.0% ·
Liquidez y Solvencia 2
Datos anuales de Liquidez y Solvencia para GRAL
Métrica Tendencia 202520242023
Current Ratio 2-point trend, +12.3% 12.0 10.7 ·
Quick Ratio 2-point trend, +10.3% 3.4 3.0 ·
Eficiencia 2
Datos anuales de Eficiencia para GRAL
Métrica Tendencia 202520242023
Asset Turnover 2-point trend, +36.8% 0.0 0.0 ·
Receivables Turnover 2-point trend, +13.1% 7.6 6.7 ·
Por Acción 5
Datos anuales de Por Acción para GRAL
Métrica Tendencia 202520242023
Book Value / Share 2-point trend, -13.5% $63.92 $73.86 ·
Revenue / Share 2-point trend, +1.7% $4.00 $3.94 ·
Cash Flow / Share 2-point trend, +55.0% $-8.14 $-18.09 ·
Cash / Share 2-point trend, -2.0% $6.19 $6.32 ·
EPS (TTM) 2-point trend, +82.5% $-11.11 $-63.54 ·
Tasas de Crecimiento 2
Datos anuales de Tasas de Crecimiento para GRAL
Métrica Tendencia 202520242023
Revenue YoY 3-point trend, -74.6% 17.2% 34.9% 67.6%
Revenue CAGR 3Y 38.4% · ·
Valoración (TTM) 10
Datos anuales de Valoración (TTM) para GRAL
Métrica Tendencia 202520242023
Revenue TTM 2-point trend, +17.2% $147M $126M ·
Net Income TTM 2-point trend, +79.9% $-408M $-2.03B ·
Market Cap 2-point trend, +470.6% $3.45B $605M ·
P/E 2-point trend, -2642.6% -7.7 -0.3 ·
P/S 2-point trend, +386.9% 23.5 4.8 ·
P/B 2-point trend, +454.0% 1.3 0.2 ·
P / Tangible Book 2-point trend, +281.7% 4.7 1.2 ·
P / Cash Flow 2-point trend, -1001.4% -11.5 -1.0 ·
P / FCF 2-point trend, -1007.9% -11.5 -1.0 ·
Earnings Yield 2-point trend, +96.4% -13.0% -356.0% ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312023-01-01
Ingresos $147M$126M$93M$56M
Margen Operativo % -382.0%-1743.0%
Beneficio neto $-408M$-2.03B$-1.47B$-5.40B
EPS Diluido $-11.11$-63.54$-47.21$-173.89
Balance general
2025-12-312024-12-312023-12-312023-01-01
Ratio corriente 12.010.7
Ratio Rápido 3.43.0
Flujo de Efectivo
2025-12-312024-12-312023-12-312023-01-01
Flujo de caja libre $-300M$-582M

Últimas noticias Noticias recientes que mencionan a esta empresa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Propietarios institucionales (13F) 411 declarantes · $2.2B total · A fecha de 30 de junio de 2026

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
67 (+16 vs trimestre anterior) 45 (-49 vs trimestre anterior) 106 (+8 vs trimestre anterior) 102 (-12 vs trimestre anterior) +6.7M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
FARALLON CAPITAL MANAGEMENT, L.L.C. $284 111 340 4 161 584 13,20% Acciones
BAKER BROS. ADVISORS LP $275 033 478 4 028 614 12,78% Acciones
STATE STREET CORP $162 859 041 2 385 514 7,57% Acciones
PRIMECAP MANAGEMENT CO/CA/ $148 835 838 2 180 106 6,91% Acciones
Sessa Capital IM, L.P. $139 101 354 2 037 518 6,46% Acciones
Deep Track Capital, LP $125 271 627 1 834 944 5,82% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $112 039 058 1 641 117 5,21% Acciones
Arbiter Partners Capital Management LLC $70 611 456 1 034 297 3,28% Acciones
GEODE CAPITAL MANAGEMENT, LLC $58 460 697 856 182 2,72% Acciones
Jefferies Financial Group Inc. $49 427 480 724 000 2,30% Acciones
Jefferies Financial Group Inc. $44 375 500 650 000 2,06% Opción de venta
DIMENSIONAL FUND ADVISORS LP $43 707 751 640 219 2,03% Acciones
GOLDMAN SACHS GROUP INC $42 579 111 623 687 1,98% Acciones
BANK OF AMERICA CORP /DE/ $42 152 219 617 434 1,96% Acciones
Casdin Capital, LLC $32 769 600 480 000 1,52% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $32 631 831 477 982 1,52% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $25 396 440 372 000 1,18% Opción de compra
SUSQUEHANNA INTERNATIONAL GROUP, LLP $24 563 546 359 800 1,14% Opción de venta
KINGDON CAPITAL MANAGEMENT, L.L.C. $23 211 800 340 000 1,08% Acciones
Granahan Investment Management, LLC $21 926 686 321 176 1,02% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $20 523 874 300 628 0,95% Acciones
Aberdeen Group plc $15 668 170 229 503 0,73% Acciones
VANGUARD FIDUCIARY TRUST CO $15 357 337 224 950 0,71% Acciones
Slow Capital, Inc. $14 832 477 217 262 0,69% Acciones
CITADEL ADVISORS LLC $14 616 607 214 100 0,68% Opción de compra
TCW GROUP INC $13 101 901 191 913 0,61% Acciones
Douglas Lane & Associates, LLC $11 082 952 162 340 0,51% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $10 601 990 155 295 0,49% Acciones
RAYMOND JAMES FINANCIAL INC $10 495 215 153 731 0,49% Acciones
Newtyn Management, LLC $10 240 500 150 000 0,48% Acciones
180 WEALTH ADVISORS, LLC $8 723 113 127 774 0,41% Acciones
Voleon Capital Management LP $8 264 903 121 062 0,38% Acciones
FMR LLC $8 139 559 119 226 0,38% Acciones
WIM INVESTMENT MANAGEMENT Ltd $7 263 928 106 400 0,34% Acciones
Alyeska Investment Group, L.P. $7 168 350 105 000 0,33% Acciones
AMERICAN CENTURY COMPANIES INC $6 774 228 99 227 0,31% Acciones
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. $5 809 000 85 089 0,27% Acciones
Swiss National Bank $5 202 174 76 200 0,24% Acciones
Susquehanna Portfolio Strategies, LLC $4 853 178 71 088 0,23% Acciones
NATIXIS $4 794 329 70 226 0,22% Acciones
CITADEL ADVISORS LLC $4 601 398 67 400 0,21% Opción de venta
BARCLAYS PLC $4 557 091 66 751 0,21% Acciones
GAMCO INVESTORS, INC. ET AL $4 554 497 66 713 0,21% Acciones
D. E. Shaw & Co., Inc. $4 444 787 65 106 0,21% Acciones
JACOBS LEVY EQUITY MANAGEMENT, INC $3 810 968 55 822 0,18% Acciones
Allianz Asset Management GmbH $3 810 695 55 818 0,18% Acciones
JANE STREET GROUP, LLC $3 775 331 55 300 0,18% Opción de compra
RHUMBLINE ADVISERS $3 773 202 55 269 0,18% Acciones
Public Sector Pension Investment Board $3 633 534 53 223 0,17% Acciones
Pictet Asset Management Holding SA $3 421 492 50 039 0,16% Acciones
Centiva Capital, LP $3 413 500 50 000 0,16% Opción de compra
Verition Fund Management LLC $3 334 921 48 849 0,15% Acciones
BlackRock, Inc. $3 131 886 45 875 0,15% Acciones
BNP PARIBAS FINANCIAL MARKETS $3 072 150 450 0,14% Opción de compra
D. E. Shaw & Co., Inc. $3 072 150 45 000 0,14% Opción de venta
Legal Advantage Investments, Inc. $3 046 549 44 625 0,14% Acciones
HighTower Advisors, LLC $2 769 342 40 565 0,13% Acciones
Rafferty Asset Management, LLC $2 697 962 39 519 0,13% Acciones
Timelo Investment Management Inc. $2 662 530 39 000 0,12% Acciones
ALLIANCEBERNSTEIN L.P. $2 492 320 48 226 0,12% Acciones
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $2 298 210 44 470 0,11% Acciones
Lido Advisors, LLC $2 270 250 33 254 0,11% Acciones
BNP PARIBAS FINANCIAL MARKETS $2 252 910 330 0,10% Opción de venta
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $2 211 768 30 719 0,10% Acciones
BNP PARIBAS FINANCIAL MARKETS $2 133 984 31 258 0,10% Acciones
Summit Financial, LLC $2 103 877 30 817 0,10% Acciones
GABELLI FUNDS LLC $2 067 420 30 283 0,10% Acciones
JONES FINANCIAL COMPANIES LLLP $1 988 740 30 169 0,09% Acciones
OSAIC HOLDINGS, INC. $1 906 981 27 934 0,09% Acciones
TWO SIGMA INVESTMENTS, LP $1 872 305 27 425 0,09% Acciones
COMMERCE BANK $1 841 993 26 981 0,09% Acciones
UBS Group AG $1 835 234 26 882 0,09% Acciones
Concurrent Investment Advisors, LLC $1 833 850 26 862 0,09% Acciones
Gem Investment Advisors, LLC $1 828 339 26 781 0,08% Acciones
VANGUARD ASSET MANAGEMENT, Ltd $1 823 765 26 714 0,08% Acciones
Legato Capital Management LLC $1 804 649 26 434 0,08% Acciones
PVG ASSET MANAGEMENT CORP $1 767 305 25 887 0,08% Acciones
CANADA PENSION PLAN INVESTMENT BOARD $1 761 366 25 800 0,08% Acciones
IMC-Chicago, LLC $1 710 368 25 053 0,08% Acciones
Jackson Hole Capital Partners, LLC $1 705 440 33 000 0,08% Acciones
Sheets Smith Investment Management $1 688 635 28 558 0,08% Acciones
MetLife Investment Management, LLC $1 649 813 24 166 0,08% Acciones
Gotham Asset Management, LLC $1 634 384 23 940 0,08% Acciones
Quantinno Capital Management LP $1 593 922 23 347 0,07% Acciones
TWO SIGMA ADVISERS, LP $1 592 060 18 601 0,07% Acciones
CLOUGH CAPITAL PARTNERS L P $1 566 387 22 944 0,07% Acciones
STATE OF WISCONSIN INVESTMENT BOARD $1 522 353 22 299 0,07% Acciones
MANUFACTURERS LIFE INSURANCE COMPANY, THE $1 474 427 21 597 0,07% Acciones
LPL Financial LLC $1 393 254 20 408 0,06% Acciones
PROFUND ADVISORS LLC $1 370 725 20 078 0,06% Acciones
Perigon Wealth Management, LLC $1 348 537 19 753 0,06% Acciones
Zurcher Kantonalbank (Zurich Cantonalbank) $1 271 324 18 622 0,06% Acciones
Invesco Ltd. $1 117 853 16 374 0,05% Acciones
Bouvel Investment Partners, LLC $1 106 998 16 215 0,05% Acciones
AMERIPRISE FINANCIAL INC $1 082 216 15 852 0,05% Acciones
NORGES BANK $1 077 983 15 790 0,05% Acciones
EXCHANGE TRADED CONCEPTS, LLC $1 054 703 15 449 0,05% Acciones
STRS OHIO $1 044 531 15 300 0,05% Acciones
PRUDENTIAL FINANCIAL INC $1 006 300 14 740 0,05% Acciones
NEW YORK STATE COMMON RETIREMENT FUND $996 469 14 596 0,05% Acciones

Informantes de la empresa 8 insiders · 2 directivos · 5 consejeros

Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Joshua J. Ofman Chief Executive Officer 1 de junio de 2026 A 402 271 0 0 $0
Andrew John Partridge Chief Growth Officer 4 de junio de 2026 S 163 738 0 1 $-91 070
William J Chase Consejero 15 de julio de 2026 A 42 978 0 0 $0
Steven Mizell Consejero 15 de julio de 2026 A 42 830 0 0 $0
Gregory L Summe Consejero 15 de julio de 2026 A 45 672 0 0 $0
Sarah Krevans Consejero 18 de junio de 2026 A 42 628 0 0 $0
ILLUMINA, INC. Propietario del 10% 17 de noviembre de 2025 S 3 502 126 0 1 $-79 850 000
Chun R Ding Propietario del 10% 9 de octubre de 2024 P 3 644 855 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 50 ETFs

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,90% 18 597 NS 30 de abril de 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,63% 59 651 NS 30 de abril de 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,21% 87 481 SH 8 de agosto de 2026 Diario
IBBQ · Invesco Exchange-Traded Fund Trust … 0,20% 2 336 SH 8 de agosto de 2026 Diario
IBB · iShares Trust 0,19% 291 644 SH 8 de agosto de 2026 Diario
VTWV · VANGUARD SCOTTSDALE FUNDS 0,18% 36 116 SH 8 de agosto de 2026 Diario
AVSC · AMERICAN CENTURY ETF TRUST 0,17% 67 501 NS 31 de mayo de 2026 N-PORT
IWN · iShares Trust 0,17% 385 837 SH 8 de agosto de 2026 Diario
ESSC · Strategy Shares 0,15% 712 NS 30 de abril de 2026 N-PORT
BIB · ProShares Trust 0,14% 1 439 NS 31 de mayo de 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,09% 237 749 SH 8 de agosto de 2026 Diario
IWM · iShares Trust 0,08% 1 053 632 SH 8 de agosto de 2026 Diario
GSSC · Goldman Sachs ETF Trust 0,08% 11 051 NS 31 de mayo de 2026 N-PORT
BKSE · BNY Mellon ETF Trust 0,08% 1 185 NS 30 de abril de 2026 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,07% 9 665 NS 30 de abril de 2026 N-PORT
ITWO · ProShares Trust 0,06% 1 654 NS 31 de mayo de 2026 N-PORT
OMFS · Invesco Exchange-Traded Self-Indexe… 0,06% 2 459 SH 8 de agosto de 2026 Diario
RSSL · Global X Funds 0,06% 15 208 NS 30 de abril de 2026 N-PORT
ESML · iShares Trust 0,05% 22 118 SH 8 de agosto de 2026 Diario
DFAS · Dimensional ETF Trust 0,05% 117 357 NS 30 de abril de 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,05% 143 168 NS 31 de mayo de 2026 N-PORT
ISCG · iShares Trust 0,04% 6 428 SH 8 de agosto de 2026 Diario
VHT · VANGUARD WORLD FUND 0,04% 114 187 SH 8 de agosto de 2026 Diario
UWM · ProShares Trust 0,04% 1 294 NS 31 de mayo de 2026 N-PORT
ISCB · iShares Trust 0,04% 1 688 SH 8 de agosto de 2026 Diario
ISCV · iShares Trust 0,04% 3 927 SH 8 de agosto de 2026 Diario
SMLF · iShares Trust 0,03% 20 757 SH 8 de agosto de 2026 Diario
FHLC · FIDELITY COVINGTON TRUST 0,03% 16 096 NS 30 de abril de 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,03% 374 291 SH 8 de agosto de 2026 Diario
URTY · ProShares Trust 0,03% 1 307 NS 31 de mayo de 2026 N-PORT
WSML · iShares Trust 0,02% 2 078 SH 8 de agosto de 2026 Diario
DXUV · Dimensional ETF Trust 0,02% 1 178 NS 30 de abril de 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,01% 1 399 NS 31 de mayo de 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,01% 23 351 NS 31 de mayo de 2026 N-PORT
HDG · ProShares Trust 0,01% 33 NS 31 de mayo de 2026 N-PORT
DCOR · Dimensional ETF Trust 0,01% 4 910 NS 30 de abril de 2026 N-PORT
ONEQ · Fidelity Commonwealth Trust 0,01% 11 015 NS 31 de mayo de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 51 657 NS 30 de abril de 2026 N-PORT
IWV · iShares Trust 0,00% 11 704 SH 8 de agosto de 2026 Diario
IETC · iShares U.S. ETF Trust 0,00% 375 SH 8 de agosto de 2026 Diario
ACVF · ETF Opportunities Trust 0,00% 82 NS 30 de abril de 2026 N-PORT
ITOT · iShares Trust 0,00% 45 817 SH 8 de agosto de 2026 Diario
AVSU · AMERICAN CENTURY ETF TRUST 0,00% 192 NS 31 de mayo de 2026 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0,00% 17 955 NS 31 de mayo de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 9 362 NS 30 de abril de 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 4 660 NS 30 de abril de 2026 N-PORT
DFUV · Dimensional ETF Trust 0,00% 3 550 NS 30 de abril de 2026 N-PORT
DFLV · Dimensional ETF Trust 0,00% 321 NS 30 de abril de 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 1 228 926 SH 8 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 3 407 SH 8 de agosto de 2026 Diario